HONG KONG - The University of Hong Kong (HKU) announced Monday it has established an innovations platform in collaboration with the Guangdong Pharmaceutical University (GDPU) to promote bio- and health technology and translational medical research and development in the Guangdong-Hong Kong-Macao Greater Bay Area.The GDPU-HKU Innovations Platform, located in Zhongshan city, includes three core units - an incubation facility, a joint laboratory and a technology transfer unit, and aims at developing into a national-level technology enterprise incubator hosting at least 50 companies and incubating at least 10 HKU technologies within five years.A satellite branch of HKU's partner state key laboratory of pharmaceutical biotechnology will also be set up at GDPU.The move is of great strategic importance to HKU in terms of technology transfer and commercialisation of the university's cutting-edge research particularly in the field of bio-medicine, HKU said in a press release, adding that it is also a significant step to mark the university's presence and contribution to development in Greater Bay Area. personalized silicone braceletsrubber bracelets custom cheappersonalized rubber braceletscheap custom wristbands
Obstetrician Zhang Yanli shows a picture of the newborn on a mobile phone. [Photo/IC] A 26-year-old woman with the rare Lou Gehrig's disease, also known as amyotrophic lateral sclerosis or ALS, has given birth to a baby via cesarean section, the second time someone with this illness has done so in China. The mother, who only gave her surname Tian, cannot move most of her body, except her right fingers to a small extent, as the disease attacks nerve cells that control muscles. She entered the hospital in Taiyuan, capital of Shanxi province, on May 2, when she was already 38 weeks pregnant. The next day, she went into the operating room at 8:45 am and her son came into the world about an hour later.
